Prosecution Insights
Last updated: May 29, 2026

Peptilogics Inc.

5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Portfolio Summary

5
Total Pending OAs
4
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (40%)
1
Medium (20%)
0
Easy (0%)
2
Unknown (40%)

Rejection Statute Mix

BucketCases
§101 only2 (40%)
§103 only1 (20%)
No statute on record2 (40%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
80% of docket
1
Information Tech
20% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WENG, PEI YONG 1 79.5% +23.0%
KONOPELSKI SNAVEL, SARA ELIZABETH 1 33.3% +30.0%
ZEMAN, MARY K 1 59.0% +34.5%
WOITACH, JOSEPH T 1 49.1% +27.5%
KRIANGCHAIVECH, KETTIP 1 20.8% +32.8%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17339598 ARTIFICIAL INTELLIGENCE ENGINE ARCHITECTURE FOR GENERATING CANDIDATE DRUGS WOITACH, JOSEPH T 25d overdue
17319839 GENERATING ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES KRIANGCHAIVECH, KETTIP 4d overdue

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18638784 GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES WENG, PEI YONG 111d overdue
17403194 ARTIFICIAL INTELLIGENCE ENGINE FOR GENERATING CANDIDATE DRUGS USING EXPERIMENTAL VALIDATION AND PEPTIDE DRUG OPTIMIZATION ZEMAN, MARY K 45d overdue
17339598 ARTIFICIAL INTELLIGENCE ENGINE ARCHITECTURE FOR GENERATING CANDIDATE DRUGS WOITACH, JOSEPH T 25d overdue
17319839 GENERATING ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES KRIANGCHAIVECH, KETTIP 4d overdue
18447414 INTRAVENOUS ADMINISTRATION OF ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES KONOPELSKI SNAVEL, SARA ELIZABETH 29d

Top Art Units

Art UnitApps
1686 2
2141 1
1658 1
1687 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18638784 GENERATING ENHANCED GRAPHICAL USER INTERFACES FOR PRESENTATION OF ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES WENG, PEI YONG 2141 Other Non-Final OA 111d overdue Pending Apr 18, 2024
18447414 INTRAVENOUS ADMINISTRATION OF ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES KONOPELSKI SNAVEL, SARA ELIZABETH 1658 Other Non-Final OA 29d Pending Aug 10, 2023
17403194 ARTIFICIAL INTELLIGENCE ENGINE FOR GENERATING CANDIDATE DRUGS USING EXPERIMENTAL VALIDATION AND PEPTIDE DRUG OPTIMIZATION ZEMAN, MARY K 1686 §103 Final Rejection 45d overdue Pending Aug 16, 2021
17339598 ARTIFICIAL INTELLIGENCE ENGINE ARCHITECTURE FOR GENERATING CANDIDATE DRUGS WOITACH, JOSEPH T 1687 §101 Non-Final OA 25d overdue Pending Jun 04, 2021
17319839 GENERATING ANTI-INFECTIVE DESIGN SPACES FOR SELECTING DRUG CANDIDATES KRIANGCHAIVECH, KETTIP 1686 §101 Non-Final OA 4d overdue Pending May 13, 2021

Managing Peptilogics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month